Cargando…

SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases. Silencing information regulator 1 (SIRT1) was demonstrated to modulate cholesterol and lipid metabolism in NAFLD. Here, a novel SIRT1 activator, E1231, was studied for its potential improvement effects on NAFLD. C57BL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Jiangxue, Li, Shunwang, Wang, Weizhi, Jiang, Xinhai, Liu, Chao, Lei, Lijuan, Li, Yining, Sheng, Ren, Zhang, Yuyan, Wu, Yexiang, Zhang, Jing, Zhang, Yuhao, Xu, Yanni, Si, Shuyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297637/ https://www.ncbi.nlm.nih.gov/pubmed/37367070 http://dx.doi.org/10.3390/cimb45060321

Ejemplares similares

Trichostatin D as a Novel KLF2 Activator Attenuates TNFα-Induced Endothelial Inflammation
por: Lei, Lijuan, et al.
Publicado: (2022)

Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism
por: Jiang, Xinhai, et al.
Publicado: (2020)

LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing
por: Li, Ni, et al.
Publicado: (2022)

COLLABORATION AGREEMENT No. K1231
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2005)

Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
por: Yan, Bao-Fei, et al.
Publicado: (2023)

LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease
por: Zou, Dongmei, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)

Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
por: Zeng, Chuanfei, et al.
Publicado: (2022)

Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats
por: Liu, Boyan, et al.
Publicado: (2020)

Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice
por: Lu, Keke, et al.
Publicado: (2020)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Emergency preparedness for mass gatherings: Lessons of “12.31” stampede in Shanghai Bund
por: Dong, Yong-He, et al.
Publicado: (2017)

Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease
por: Hu, Zongqiang, et al.
Publicado: (2023)

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
por: Colak, Yasar, et al.
Publicado: (2011)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

A retrospective analysis of 1,231 patients with anemia after surgical treatment of hyperthyroidism
por: Tu, Ruisha, et al.
Publicado: (2018)

1231. Development of state public health goals for antimicrobial stewardship using local data
por: Biehle, Lauren, et al.
Publicado: (2023)

MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
por: Zhang, Jiale, et al.
Publicado: (2018)

Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
por: Yang, Jiayao, et al.
Publicado: (2020)

B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36
por: Zhang, Hao, et al.
Publicado: (2022)

Harnessing the Therapeutic Potential of Ginsenoside Rd for Activating SIRT6 in Treating a Mouse Model of Nonalcoholic Fatty Liver Disease
por: Cui, Tianqi, et al.
Publicado: (2023)

MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus
por: Li, Jing, et al.
Publicado: (2020)

Production, purification, sequencing and activity spectra of mutacins D-123.1 and F-59.1
por: Nicolas, Guillaume G, et al.
Publicado: (2011)

Common variation at 10p12.31 near MLLT10 influences meningioma risk
por: Dobbins, Sara E, et al.
Publicado: (2011)

1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness
por: Pizzuto, Matteo Samuele, et al.
Publicado: (2020)

Single incision laparoscopic totally extraperitoneal hernioplasty: lessons learned from 1,231 procedures
por: Lee, Yoo Jung, et al.
Publicado: (2021)

NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin
por: Li, Dong-Jie, et al.
Publicado: (2021)

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019)

Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms
por: Mak, Kit-Kay, et al.
Publicado: (2023)

Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease
por: Liao, Tzu-Chieh, et al.
Publicado: (2022)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

SIRT2 Deficiency Aggravates Diet-Induced Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites
por: Li, Xingyu, et al.
Publicado: (2023)

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
por: Ye, Qingyan, et al.
Publicado: (2023)

1231. Patient-Level Factors Associated with Vancomycin-Resistant Enterococci Transmission to Healthcare Workers Gowns or Gloves
por: Blanco, Natalia, et al.
Publicado: (2018)

Knockdown of lncRNA ABHD11-AS1 Suppresses the Tumorigenesis of Pancreatic Cancer via Sponging miR-1231
por: Liu, Bowei, et al.
Publicado: (2020)

Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease
por: Jiang, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndvs7s9nb6ht972uku23crbl7t